The Luo lab studies hypoxia stress in human cancers with a focus on epigenetic and metabolic alterations. 

Our laboratory is interested in studying the intersection between lung cancer and immunology. We are currently focused on co-opting innate immune signaling pathways and tumor-associated T cell populations to target diverse subsets of lung cancer.

The overarching goal of the Liu Lab is to redefine membrane enzymology.

The Liu Lab studies the seasonal clock and its roles in human health. We use a new seasonal primate model, the mouse lemur, and an interdisciplinary approach of molecular biology, genetics, omics, machine learning, and computational modeling. We also apply the mouse lemur primate model to study pathophysiology that is poorly represented in mice, with a focus on neurodegeneration, immunology, and metabolism.

research lab at UT Southwestern for Yun "Claudia" Wei, Ph.D.

The goal of the Choi Lab is to develop novel immunotherapies. To accomplish this, we first utilize high-dimensional approaches on human disease samples. This approach identifies targetable disease-promoting molecular defects in immune cells. Then, we utilize engineering approaches ot reverse the molecular changes.

The Neuro-Oncology Translational Research Laboratory studies primary brain tumors from pure basic science through the continuum to clinical trials. 

Our laboratory is interested in understanding how the ubiquitin-mediated protein degradation regulates gene expression and how failure of these pathways contributes to developmental disorders and diseases, such as neurodegeneration and cancer.

Research lab led by PI Faith (Yuanyuan) Zhang, M.D., Ph.D.

The Ranjan Lab’s mission is to develop and translate novel immunotherapies, with a particular focus on addressing malignant cancers in humans and animals.